Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - RESEARCH & DEVELOPMENT
Research & Development EXEL - Exelixis, Inc.
1.04 B
LAST VALUE
22.68%
2 YEAR CAGR
41.78%
5 YEAR CAGR
19.30%
10 YEAR CAGR